virus – Page 3 – One America News Network

TOPSHOT - A nurse wearing personal protective equipment (PPE) in a tent on the grounds of the Sophiahemmet private hospital, perform tests on a patient to see if she has symptoms of COVID-19 on April 22, 2020 in Stockholm. - Those who are deemed not to be suffering from COVID-19 are allowed to go to a primary care centre for treatment for their condition while those who are presenting symptoms of the virus are told to return home to self-isolate or, in severe cases, sent to hospital for care (Photo by Jonathan NACKSTRAND / AFP) (Photo by JONATHAN NACKSTRAND/AFP via Getty Images)

‘Deadliest Strain’ Of Monkeypox Makes Its Way To Europe Following Swede’s Trip To Africa

Swedish health officials have announced the first infection of a new potent strain of Monkeypox (mpox) in the country, which marks the first official case outside of Africa.

Video still from Tipping Point on One America News Network during an interview with the guest, Dr. Scott Atlas.

Latest Pandemic Rollout

with with Dr. Scott Atlas

FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell

CDC: Almost 200 Cases Of Dengue Virus Reported In N.Y. And New Jersey

The Centers for Disease Control and Prevention (CDC) reported that so far this year, almost 200 individuals in the states of New York and New Jersey have contracted dengue.

CARMARTHEN, WALES - APRIL 07: A nurse prepares the Moderna Covid-19 vaccine, at the West Wales General Hospital in Carmarthen, on April 7, 2021 in Carmarthen, Wales. Moderna, the third vaccine to be approved for use in the UK, is to be given to patients in Wales from Wednesday. Five thousand doses of the vaccine were sent to vaccination centres in the Hywel Dda University Health Board area on Tuesday. The vaccine's approval by the UK's Medicines and Healthcare products Regulatory Agency was announced on January 8. The UK has bought 17 million doses of the Moderna jab enough for 8.5 million people. (Photo by Jacob King - WPA Pool/Getty Images)

U.S. Set To Pay Moderna $176M To Develop A Bird Flu Vaccine

The U.S. government will pay vaccine maker Moderna $176 million to increase the development of a pandemic influenza vaccine that could be used to treat bird flu, federal officials announced on Tuesday.